HC Wainwright & Co. Reiterates Buy on Ocugen, Maintains $7 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a Buy rating on Ocugen (NASDAQ:OCGN) and maintained a $7 price target.

February 22, 2024 | 11:46 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reiterates a Buy rating on Ocugen with a $7 price target.
The reiteration of a Buy rating and maintenance of a $7 price target by a reputable analyst firm like HC Wainwright & Co. could instill confidence among investors and potentially lead to a positive short-term impact on Ocugen's stock price. Analyst ratings often influence investor perception and can lead to price movements.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100